We have updated our Panel for Cardiac Diseases. It has been expanded by 46 genes to cover 202 genes in total, grouped into 15 gene sets. This significantly increases the likelihood of finding the causal variant for genetic cardiac diseases.
Our Diagnostic Panel helps to detect cardiac diseases at an early stage so that targeted, preventive measures can be taken. Based on recent scientific findings we have updated all gene sets of the panel. Particularly noteworthy in this context is the gene set for isolated and syndromal congenital heart defects (HRT09), which has been expanded by 39 genes.
The Panel for Cardiac Diseases was enlarged by the following gene sets and phenotypes:
- Cardiomyopathy with onset in neonatal period, infancy or childhood (HRT13)
- Neuromuscular diseases with cardiomyopathy (HRT14)
- Pulmonary arterial hypertension (HRT15)
- Hypercholesterolemia and Hyperlipoproteinemia (HRT16)
Please also note our cost and time efficient large panel approach. We always sequence all genes of a panel and analyze the ordered gene set. As a result, we can quickly expand the analysis to any desired gene set for only little additional costs. Furthermore, all diagnostic panels include a panel-wide deletion/duplication screening using the copy number variation (CNV) track. We validate our analysis by means of MLPA or qPCR in case of irregularities. The del/dup analysis contributes to CeGaT’s high quality medical reports to provide you with all major analysis options available.